Table 1. Demographic and clinical data of the study participants.
Characteristic | AD N (20) | PD N (20) | Control N (20) | p-value |
---|---|---|---|---|
Age, (Y) | 72.5 ± 7.68 | 73 ± 8.07 | 66.1 ± 7.79 | - |
Male sex-no (%) | 40 | 45 | 25 | - |
Smoker (%) | 15 | 10 | 15 | - |
Ex-smoker (%) | 5 | 20 | 5 | - |
MMSE | 18.15 ± 5.4 | 22.45 ± 5.46 | 28.7 ± 1.11 | ≤ 0.05 |
CDR-SOB | 6.25 ± 2.67 | 2.6 ± 2.94 | 0.23 ± 0.25 | ≤ 0.05 |
H-Y | NA | 2.31 ± 0.58 | NA |
Values are represented as mean ± SD. MMSE scores range from 0 (severe impairment) to 30 (no impairment). A score of higher than 27 was considered normal. CDR-SOB scores range from 0 (cognitive normality) to 18 (maximal cognitive impairment). Hoehn and Yahr (H-Y) scores range from stage 1 (mild) to stage 5 (maximal disabling). The p-value that evaluates statistical significance between these variables was computed using the one-way ANOVA.